Skip to content

    Can Podcasts Help Improve Adoption of HER2-Low Therapies?

    At the 2026 ISPOR Annual Meeting, Dr. Jessica Paulus presented research on how targeted education can improve real-world adoption of HER2-low therapies for metastatic breast cancer.